Real-time in vivo imaging of p16Ink4a reveals cross talk with p53
Open accessThe DOI matches its Crossref record; 68 of the 71 references it cites were found in a registry or an index.
Abstract
Expression of the p16Ink4a tumor suppressor gene, a sensor of oncogenic stress, is up-regulated by a variety of potentially oncogenic stimuli in cultured primary cells. However, because p16Ink4a expression is also induced by tissue culture stress, physiological mechanisms regulating p16Ink4a expression remain unclear. To eliminate any potential problems arising from tissue culture–imposed stress, we used bioluminescence imaging for noninvasive and real-time analysis of p16Ink4a expression under various physiological conditions in living mice. In this study, we show that oncogenic insults such as ras activation provoke epigenetic derepression of p16Ink4a expression through reduction of DNMT1 (DNA methyl transferase 1) levels as a DNA damage response in vivo. This pathway is accelerated in the absence of p53, indicating that p53 normally holds the p16Ink4a response in check. These results unveil a backup tumor suppressor role for p16Ink4a in the event of p53 inactivation, expanding our understanding of how p16Ink4a expression is regulated in vivo.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







![Figure 8. Induction of p16Ink4a gene expression in p53 knockout mice. (A) p16-luc mice lacking the p53 gene (p53−/−) or their wild-type controls (p53+/+) were subjected to noninvasive BLI at the indicated age. The same mice were then incised under anesthesia (photographed under regular light) and subjected to BLI again (invasive BLI). Representative images of five different experiments are shown. The color bars indicate photons with minimum and maximum threshold values. Schematic drawings illustrating the mouse bodies are shown (dotted lines). The arrows show bioluminescence signals derived from thymus. (B–F) Thymus tissue was isolated from both genotypes of 10-wk-old mice (A) and subjected to analysis of quantitative real-time RT-PCR (RT-qPCR) for p16Ink4a gene expression (B) or DNMT1 gene expression (F) or histochemistry (hematoxylin and eosin [H&E] staining and SA β-gal staining; E), γ-H2AX foci (C), or intracellular levels of ROS (D). The means ± SD of three independent experiments are shown.](https://figures.cochat.ai/paper-figures/2a0a4f510d9b4212af8365182c669f72/real-time-in-vivo-imaging-of-p16ink4a-reveals-cross-talk-with-p53-figure-8.jpg)

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“CDKN2A mRNA levels are regulated by transcription and mRNA stability104,111.”
From Guidelines for minimal information on cellular senescence experimentation in vivo (2024) · cites this paper as [111]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Both p16 and p53 display compensatory interactions [236], [237] and both have a role in senescence initiation and maintenance [79], [238], [239].”
From Redox control of senescence and age-related disease. (2017) · cites this paper as [237]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“senescent cells are viable for long periods of time and thereby accumulate with age in various organs and tissues5–7.”
From A BET family protein degrader provokes senolysis by targeting NHEJ and autophagy in senescent cells (2020) · cites this paper as [7]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Senescent cells have been observed to accumulate due to various in vivo stresses during the aging process (4–6).”
From Chromatin conformational changes at human satellite II contribute to the senescence phenotype in the tumor microenvironment (2023) · cites this paper as [4]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“p16 is considered the best marker of senescent cells, and its expression is upregulated in many tissues during ageing [10 -12].”
From The role of cellular senescence and SASP in tumour microenvironment (2023) · cites this paper as [11]
Experimental — accuracy not yet measured
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Oncogenic activity of Cdc6 through repression of the INK4/ARF locus
Gonzalez, S., Klatt, P., Delgado, S., Conde, E., Lopez-Rios, F., Sanchez-Cespedes, M., Mendez, J., Antequera, F., & Serrano, M. (2006) · Nature · doi:10.1038/nature04585 · Cited by 186 · cited 1×
“…and that the p16Ink4a gene is subject to multiple levels of control (Jacobs et al., 1999; Passegué and Wagner, 2000; Ohtani et al., 2001, 2003; Gonzalez et al., 2006; Bracken et al., 2007; Kotake et al., 2007; Baker et al., 2008; Kia et al., 2008; Agger et al., 2009; Barradas et al., 2009;…”
RetractedOxidants, oxidative stress and the biology of ageing
Finkel, T., & Holbrook, N. J. (2000) · Nature · doi:10.1038/35041687 · Cited by 9,413 · cited 1×
“S5 A; Finkel and Holbrook, 2000; Macleod, 2008), and increased levels of ROS are shown to be essential for the onset of oncogenic Ras–induced senescence in cultured HDFs (Lee et al., 1999).”
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477 · cited 2×
“The levels of bioluminescent signals were well correlated with those of endogenous p16Ink4a expression as well as other senescence markers such as senescence-associated (SA) -galactosidase (-gal) activity (Dimri et al., 1995) and dephosphorylation of pRb (Fig.”
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218 · cited 11×
“4 B), implying that the effect or effects of oncogenic Ras signaling on the p16Ink4a promoter (Serrano et al., 1997; Ohtani et al., 2001) may be counteracted in early papillomas.”
InfluentialMice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A., Butel, J. S., & Bradley, A. (1992) · Nature · doi:10.1038/356215a0 · Cited by 4,649 · cited 2×
“However, because p53 knockout mice are highly susceptible to thymic lymphoma (Donehower et al., 1992), induction of p16Ink4a appears to be insufficient for long-term stability of senescence cell cycle arrest in the absence of p53, which is the guardian of the genome.”
Targeted mutation of the DNA methyltransferase gene results in embryonic lethality
Li, E., Bestor, T. H., & Jaenisch, R. (1992) · Cell · doi:10.1016/0092-8674(92)90611-f · Cited by 3,984 · cited 1×
“…hypothesis and to delineate the molecular mechanisms involved, we next used primary HDFs because mice lacking the DNMT1 gene are embryonic lethal (Li et al., 1992) and the p16Ink4a gene is exquisitely sensitive to tissue culture stress in mouse primary cells (Zindy et al., 1997; Parrinello et…”
Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors
Campisi, J. (2005) · Cell · doi:10.1016/j.cell.2005.02.003 · Cited by 2,379 · cited 5×
“, 1995) and dephosphorylation of pRb (Fig. 4, A–C; Campisi, 2005), indicating that oncogenic”
InfluentialRb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence
Narita, M., Nuñez, S., Heard, E., Narita, M., Lin, A. W., Hearn, S. A., Spector, D. L., Hannon, G. J., & Lowe, S. W. (2003) · Cell · doi:10.1016/s0092-8674(03)00401-x · Cited by 2,278 · cited 2×
“It is noteworthy that Narita et al. (2003) have reported an increase in H3K9 methylation specifically at E2F target 405REAL-TIME IN VIVO IMAGING OF P16 EXPRESSION • Yamakoshi et al. Blend Taq polymerase (TOYOBO) with primers specific for the mouse p16Ink4a gene, human p16Ink4a gene, and mouse…”
MethodVousden, K. H., & Lane, D. P. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2147 · Cited by 2,272 · cited 1×
“Importantly, moreover, this pathway is more potentiated in the setting of p53 deletion because p53 tends to prevent proliferation of damaged cells that cause further accumulation of DNA damage (Fig. 9; Vousden and Lane, 2007; Riley et al., 2008).”
BRAFE600-associated senescence-like cell cycle arrest of human naevi
Michaloglou, C., Vredeveld, L. C. W., Soengas, M. S., Denoyelle, C., Kuilman, T., van der Horst, C. M. A. M., Majoor, D. M., Shay, J. W., Mooi, W. J., & Peeper, D. S. (2005) · Nature · doi:10.1038/nature03890 · Cited by 2,160 · cited 2×
“Some contribution to cellular senescence presumably underlies the importance of p16Ink4a as a tumor suppressor, but the roles and mechanisms regulating its expression in vivo remain elusive (Michaloglou et al., 2005; Gil and Peters, 2006; Kim and Sharpless, 2006; Takahashi et al., 2006).”
Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints
Bartkova, J., Rezaei, N., Liontos, M., Karakaidos, P., Kletsas, D., Issaeva, N., Vassiliou, L.-V. F., Kolettas, E., Niforou, K., Zoumpourlis, V. C., et al. (2006) · Nature · doi:10.1038/nature05268 · Cited by 1,986 · cited 1×
“…lines of evidence suggest that DDRs triggered by hyper–cell proliferation play a key role or roles in the onset of oncogene-induced senescence (Bartkova et al., 2006; Di Micco et al., 2006; Mallette et al., 2007), we next asked whether DDR triggered by hyper–cell proliferation might be…”
Transcriptional control of human p53-regulated genes
Riley, T., Sontag, E., Chen, P., & Levine, A. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2395 · Cited by 1,921 · cited 2×
“9; Vousden and Lane, 2007; Riley et al., 2008).”
Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication
Di Micco, R., Fumagalli, M., Cicalese, A., Piccinin, S., Gasparini, P., Luise, C., Schurra, C., Garre’, M., Giovanni Nuciforo, P., Bensimon, A., et al. (2006) · Nature · doi:10.1038/nature05327 · Cited by 1,821 · cited 1×
“…that DDRs triggered by hyper–cell proliferation play a key role or roles in the onset of oncogene-induced senescence (Bartkova et al., 2006; Di Micco et al., 2006; Mallette et al., 2007), we next asked whether DDR triggered by hyper–cell proliferation might be involved in the reduction of…”
Jacobs, J. J. L., Kieboom, K., Marino, S., DePinho, R. A., & van Lohuizen, M. (1999) · Nature · doi:10.1038/16476 · Cited by 1,580 · cited 2×
“…of p16Ink4a regulation cannot be explained by factors described in this study and that the p16Ink4a gene is subject to multiple levels of control (Jacobs et al., 1999; Passegué and Wagner, 2000; Ohtani et al., 2001, 2003; Gonzalez et al., 2006; Bracken et al., 2007; Kotake et al., 2007; Baker et…”
Ink4a/Arf expression is a biomarker of aging
Krishnamurthy, J., Torrice, C., Ramsey, M. R., Kovalev, G. I., Al-Regaiey, K., Su, L., & Sharpless, N. E. (2004) · Journal of Clinical Investigation · doi:10.1172/jci22475 · Cited by 1,486 · cited 1×
“Moreover, as the levels of mouse p16Ink4a gene expression are increased in many different tissues with age (Zindy et al., 1997; Krishnamurthy et al., 2004), the levels of bioluminescent signals in p16-luc mice were dramatically increased during the aging process throughout the body (Fig.”
To cycle or not to cycle: a critical decision in cancer
Malumbres, M., & Barbacid, M. (2001) · Nature Reviews Cancer · doi:10.1038/35106065 · Cited by 1,468 · cited 1×
“Bisulfite sequencing analysis was performed as described previously (Suzuki et al., 2006). et al., 2002; Terzian et al., 2008) and why the combination of p53 and p16Ink4a loss frequently occurred in human cancer cells (Malumbres and Barbacid, 2001).”
Lowe, S. W., Cepero, E., & Evan, G. (2004) · Nature · doi:10.1038/nature03098 · Cited by 1,309 · cited 2×
“JCB: ARTICLE”
Oxygen sensitivity severely limits the replicative lifespan of murine fibroblasts
Parrinello, S., Samper, E., Krtolica, A., Goldstein, J., Melov, S., & Campisi, J. (2003) · Nature Cell Biology · doi:10.1038/ncb1024 · Cited by 1,116 · cited 2×
“…and to delineate the molecular mechanisms involved, we next used primary HDFs because mice lacking the DNMT1 gene are embryonic lethal (Li et al., 1992) and the p16Ink4a gene is exquisitely sensitive to tissue culture stress in mouse primary cells (Zindy et al., 1997; Parrinello et al., 2003).”
The Regulation of INK4/ARF in Cancer and Aging
Kim, W. Y., & Sharpless, N. E. (2006) · Cell · doi:10.1016/j.cell.2006.10.003 · Cited by 1,009 · cited 4×
“Some contribution to cellular senescence presumably underlies the importance of p16Ink4a as a tumor suppressor, but the roles and mechanisms regulating its expression in vivo remain elusive (Michaloglou et al., 2005; Gil and Peters, 2006; Kim and Sharpless, 2006; Takahashi et al., 2006).”
InfluentialLin, A. W., Barradas, M., Stone, J. C., van Aelst, L., Serrano, M., & Lowe, S. W. (1998) · Genes & Development · doi:10.1101/gad.12.19.3008 · Cited by 945 · cited 2×
“JCB: ARTICLE”
Carcinogen-specific mutation and amplification of Ha-ras during mouse skin carcinogenesis
Quintanilla, M., Brown, K., Ramsden, M., & Balmain, A. (1986) · Nature · doi:10.1038/322078a0 · Cited by 859 · cited 3×
“In agreement with previous studies (Quintanilla et al., 1986; Kemp, 2005), benign skin papillomas began to appear after 7 wk of treatment and continued to grow to a larger 397REAL-TIME IN VIVO IMAGING OF P16 EXPRESSION • Yamakoshi et al. JCB • VOLUME 186 • NUMBER 3 • 2009 398 399REAL-TIME IN VIVO…”
Bracken, A. P., Kleine-Kohlbrecher, D., Dietrich, N., Pasini, D., Gargiulo, G., Beekman, C., Theilgaard-Mönch, K., Minucci, S., Porse, B. T., Marine, J.-C., et al. (2007) · Genes & Development · doi:10.1101/gad.415507 · Cited by 850 · cited 6×
“(D) The precipitated DNA was amplified by real-time quantitative PCR using primers specific for the p16Ink4a gene promoter described previously (Bracken et al., 2007).”
InfluentialRegulation of the INK4b–ARF–INK4a tumour suppressor locus: all for one or one for all
Gil, J., & Peters, G. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1987 · Cited by 843 · cited 5×
“JCB: ARTICLE”
InfluentialSenescence of human fibroblasts induced by oncogenic Raf
Zhu, J., Woods, D., McMahon, M., & Bishop, J. M. (1998) · Genes & Development · doi:10.1101/gad.12.19.2997 · Cited by 826 · cited 2×
“For example, in cultured primary human fibroblasts, ectopic expression of oncogenic Ras or its downstream mediator initiates cellular senescence, the state of irreversible cell cycle arrest, through up-regulation of Cdk inhibitors such as p16 (Serrano et al., 1997; Lin et al., 1998; Zhu et al., 1998; Ohtani et al., 20…”
Regulation of p16 CDKN2 Expression and Its Implications for Cell Immortalization and Senescence
Hara, E., Smith, R., Parry, D., Tahara, H., Stone, S., & Peters, G. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.3.859 · Cited by 733 · cited 1×
“Induction of p16Ink4a expression in cellular senescence and organismal aging Because induction of p16Ink4a expression is a hallmark of cellular senescence (Hara et al., 1996; Serrano et al., 1997), we next asked whether the human p16Ink4a gene responds to senescence stimuli in murine cells.”
Self-citationRas Proteins Induce Senescence by Altering the Intracellular Levels of Reactive Oxygen Species
Lee, A. C., Fenster, B. E., Ito, H., Takeda, K., Bae, N. S., Hirai, T., Yu, Z.-X., Ferrans, V. J., Howard, B. H., & Finkel, T. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.12.7936 · Cited by 691 · cited 1×
“S5 A; Finkel and Holbrook, 2000; Macleod, 2008), and increased levels of ROS are shown to be essential for the onset of oncogenic Ras–induced senescence in cultured HDFs (Lee et al., 1999).”
Opposing effects of Ets and Id proteins on p16INK4a expression during cellular senescence
Ohtani, N., Zebedee, Z., Huot, T. J. G., Stinson, J. A., Sugimoto, M., Ohashi, Y., Sharrocks, A. D., Peters, G., & Hara, E. (2001) · Nature · doi:10.1038/35059131 · Cited by 654 · cited 8×
“4 B), implying that the effect or effects of oncogenic Ras signaling on the p16Ink4a promoter (Serrano et al., 1997; Ohtani et al., 2001) may be counteracted in early papillomas.”
InfluentialSelf-citationDNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells
Robert, M.-F., Morin, S., Beaulieu, N., Gauthier, F., Chute, I. C., Barsalou, A., & MacLeod, A. R. (2003) · Nature Genetics · doi:10.1038/ng1068 · Cited by 614 · cited 4×
“Interestingly, the levels of DNMT1, which is a negative regulator of p16 gene expression (Robert et al., 2003), were substantially increased in early papillomas”
InfluentialZindy, F., Quelle, D. E., Roussel, M. F., & Sherr, C. J. (1997) · Oncogene · doi:10.1038/sj.onc.1201178 · Cited by 574 · cited 4×
“Moreover, as the levels of mouse p16Ink4a gene expression are increased in many different tissues with age (Zindy et al., 1997; Krishnamurthy et al., 2004), the levels of bioluminescent signals in p16-luc mice were dramatically increased during the aging process throughout the body (Fig.”
InfluentialDirect interaction between DNMT1 and G9a coordinates DNA and histone methylation during replication
Estève, P.-O., Chin, H. G., Smallwood, A., Feehery, G. R., Gangisetty, O., Karpf, A. R., Carey, M. F., & Pradhan, S. (2006) · Genes & Development · doi:10.1101/gad.1463706 · Cited by 536 · cited 4×
“It has recently been shown that DNMT1 also possesses an activity to enhance H3K9 methylation through interacting with G9a, a major H3K9 mono- and dimethyltransferase (Estève et al., 2006).”
InfluentialTakahashi, A., Ohtani, N., Yamakoshi, K., Iida, S.-I., Tahara, H., Nakayama, K., Nakayama, K. I., Ide, T., Saya, H., & Hara, E. (2006) · Nature Cell Biology · doi:10.1038/ncb1491 · Cited by 528
Self-citationDose-dependent oncogene-induced senescence in vivo and its evasion during mammary tumorigenesis
Sarkisian, C. J., Keister, B. A., Stairs, D. B., Boxer, R. B., Moody, S. E., & Chodosh, L. A. (2007) · Nature Cell Biology · doi:10.1038/ncb1567 · Cited by 490 · cited 2×
“We first reasoned that the long latency period of p16 gene expression may be caused by a spontaneous up-regulation of the intensity of Ras signaling because high levels but not low levels of oncogenic Ras expression have been shown to induce p16 gene expression in transgenic mice carrying a tetracycline-inducible ras…”
Nguyen, C. T., Weisenberger, D. J., Velicescu, M., Gonzales, F. A., Lin, J., Liang, G., & Jones, P. A. (2002) · PubMed · Cited by 444
Putative telomere-independent mechanisms of replicative aging reflect inadequate growth conditions
Ramirez, R. D., Morales, C. P., Herbert, B.-S., Rohde, J. M., Passons, C., Shay, J. W., & Wright, W. E. (2001) · Genes & Development · doi:10.1101/gad.859201 · Cited by 444 · cited 2×
“However, because human p16Ink4a gene expression is also induced by tissue culture–imposed stress (Ramirez et al., 2001; Benanti and Galloway, 2004; Ince et al., 2007; Shay and Wright, 2007), it remains unclear whether the induction of human p16Ink4a gene expression in tissuecultured cells truly…”
Agger, K., Cloos, P. A. C., Rudkjær, L., Williams, K., Andersen, G., Christensen, J., & Helin, K. (2009) · Genes & Development · doi:10.1101/gad.510809 · Cited by 427 · cited 2×
“…multiple levels of control (Jacobs et al., 1999; Passegué and Wagner, 2000; Ohtani et al., 2001, 2003; Gonzalez et al., 2006; Bracken et al., 2007; Kotake et al., 2007; Baker et al., 2008; Kia et al., 2008; Agger et al., 2009; Barradas et al., 2009; Tzatsos et al., 2009; Witcher and Emerson, 2009).”
Histone modifications and silencing prior to DNA methylation of a tumor suppressor gene
Bachman, K. E., Park, B. H., Rhee, I., Rajagopalan, H., Herman, J. G., Baylin, S. B., Kinzler, K. W., & Vogelstein, B. (2003) · Cancer Cell · doi:10.1016/s1535-6108(02)00234-9 · Cited by 418 · cited 2×
“lines (Nguyen et al., 2002; Bachman et al., 2003), led us to the hypothesis that the levels of DNMT1 may regulate p16 expression, at least partly, through altering the levels of H3K9me2 around the p16 gene promoter region during DMBA/TPAinduced skin papilloma development.”
Putting the stress on senescence
Serrano, M., & Blasco, M. A. (2001) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(00)00278-7 · Cited by 413 · cited 2×
“cogenic stimuli derives from studies undertaken in cultured primary cells (Serrano and Blasco, 2001; Gil and Peters, 2006; Kim and Sharpless, 2006).”
Opposing roles for p16Ink4a and p19Arf in senescence and ageing caused by BubR1 insufficiency
Baker, D. J., Perez-Terzic, C., Jin, F., Pitel, K. S., Niederländer, N. J., Jeganathan, K., Yamada, S., Reyes, S., Rowe, L., Hiddinga, H. J., et al. (2008) · Nature Cell Biology · doi:10.1038/ncb1744 · Cited by 408 · cited 2×
“…multiple levels of control (Jacobs et al., 1999; Passegué and Wagner, 2000; Ohtani et al., 2001, 2003; Gonzalez et al., 2006; Bracken et al., 2007; Kotake et al., 2007; Baker et al., 2008; Kia et al., 2008; Agger et al., 2009; Barradas et al., 2009; Tzatsos et al., 2009; Witcher and Emerson, 2009).”
The DNA damage signaling pathway is a critical mediator of oncogene-induced senescence
Mallette, F. A., Gaumont-Leclerc, M.-F., & Ferbeyre, G. (2007) · Genes & Development · doi:10.1101/gad.1487307 · Cited by 406 · cited 1×
“…by hyper–cell proliferation play a key role or roles in the onset of oncogene-induced senescence (Bartkova et al., 2006; Di Micco et al., 2006; Mallette et al., 2007), we next asked whether DDR triggered by hyper–cell proliferation might be involved in the reduction of DNMT1 level in late…”
The inherent instability of mutant p53 is alleviated by Mdm2 or p16 INK4a loss
Terzian, T., Suh, Y.-A., Iwakuma, T., Post, S. M., Neumann, M., Lang, G. A., Van Pelt, C. S., & Lozano, G. (2008) · Genes & Development · doi:10.1101/gad.1662908 · Cited by 357 · cited 1×
“Bisulfite sequencing analysis was performed as described previously (Suzuki et al., 2006). et al., 2002; Terzian et al., 2008) and why the combination of p53 and p16Ink4a loss frequently occurred in human cancer cells (Malumbres and Barbacid, 2001).”
Histone demethylase JMJD3 contributes to epigenetic control of INK4a/ARF by oncogenic RAS
Barradas, M., Anderton, E., Acosta, J. C., Li, S., Banito, A., Rodriguez-Niedenführ, M., Maertens, G., Banck, M., Zhou, M.-M., Walsh, M. J., et al. (2009) · Genes & Development · doi:10.1101/gad.511109 · Cited by 352 · cited 2×
“…multiple levels of control (Jacobs et al., 1999; Passegué and Wagner, 2000; Ohtani et al., 2001, 2003; Gonzalez et al., 2006; Bracken et al., 2007; Kotake et al., 2007; Baker et al., 2008; Kia et al., 2008; Agger et al., 2009; Barradas et al., 2009; Tzatsos et al., 2009; Witcher and Emerson, 2009).”
JunB suppresses cell proliferation by transcriptional activation of p16INK4a expression
Passegue, E. (2000) · The EMBO Journal · doi:10.1093/emboj/19.12.2969 · Cited by 332 · cited 1×
“…cannot be explained by factors described in this study and that the p16Ink4a gene is subject to multiple levels of control (Jacobs et al., 1999; Passegué and Wagner, 2000; Ohtani et al., 2001, 2003; Gonzalez et al., 2006; Bracken et al., 2007; Kotake et al., 2007; Baker et al., 2008; Kia et…”
Kotake, Y., Cao, R., Viatour, P., Sage, J., Zhang, Y., & Xiong, Y. (2007) · Genes & Development · doi:10.1101/gad.1499407 · Cited by 311 · cited 2×
“This is very important because BMI-1, which is a negative regulator of p16Ink4a gene expression (Jacobs et al., 1999), is known to bind not only to the promoter region but also to the intron region of the p16Ink4a locus (Bracken et al., 2007; Kotake et al., 2007).”
Transformation of Different Human Breast Epithelial Cell Types Leads to Distinct Tumor Phenotypes
Ince, T. A., Richardson, A. L., Bell, G. W., Saitoh, M., Godar, S., Karnoub, A. E., Iglehart, J. D., & Weinberg, R. A. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.06.013 · Cited by 309 · cited 2×
“JCB: ARTICLE”
p15Ink4b is a critical tumour suppressor in the absence of p16Ink4a
Krimpenfort, P., IJpenberg, A., Song, J.-Y., van der Valk, M., Nawijn, M., Zevenhoven, J., & Berns, A. (2007) · Nature · doi:10.1038/nature06084 · Cited by 269
SWI/SNF Mediates Polycomb Eviction and Epigenetic Reprogramming of the INK4b-ARF-INK4a Locus
Kia, S. K., Gorski, M. M., Giannakopoulos, S., & Verrijzer, C. P. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.02019-07 · Cited by 265 · cited 1×
“…multiple levels of control (Jacobs et al., 1999; Passegué and Wagner, 2000; Ohtani et al., 2001, 2003; Gonzalez et al., 2006; Bracken et al., 2007; Kotake et al., 2007; Baker et al., 2008; Kia et al., 2008; Agger et al., 2009; Barradas et al., 2009; Tzatsos et al., 2009; Witcher and Emerson, 2009).”
Witcher, M., & Emerson, B. M. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.04.001 · Cited by 235 · cited 1×
“…multiple levels of control (Jacobs et al., 1999; Passegué and Wagner, 2000; Ohtani et al., 2001, 2003; Gonzalez et al., 2006; Bracken et al., 2007; Kotake et al., 2007; Baker et al., 2008; Kia et al., 2008; Agger et al., 2009; Barradas et al., 2009; Tzatsos et al., 2009; Witcher and Emerson, 2009).”
The differential impact of p16INK4a or p19ARF deficiency on cell growth and tumorigenesis
Sharpless, N. E., Ramsey, M. R., Balasubramanian, P., Castrillon, D. H., & DePinho, R. A. (2004) · Oncogene · doi:10.1038/sj.onc.1207074 · Cited by 224 · cited 3×
“These results are somewhat consistent with a previous study showing that the tumor-free survival of DMBAtreated mice was substantially reduced in p16Ink4a knockout mice (Sharpless et al., 2004).”
InfluentialImmunohistochemical survey of p16INK4A expression in normal human adult and infant tissues.
Nielsen, G. P., Stemmer-Rachamimov, A. O., Shaw, J., Roy, J. E., Koh, J., & Louis, D. N. (1999) · PubMed · Cited by 195
Regulation of DNA Methylation by the Ras Signaling Pathway
MacLeod, A. R., Rouleau, J., & Szyf, M. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.19.11327 · Cited by 185 · cited 2×
“…of human p16Ink4a gene expression has remained incompletely defined, at least in part, because p16Ink4a gene expression is rapidly induced by tissue culture stress in It is also interesting to note that oncogenic Ras signaling is shown to activate the DNMT1 gene promoter (MacLeod et al., 1995).”
Regulation of DNA Methyltransferase 1 by the pRb/E2F1 Pathway
McCabe, M. T., Davis, J. N., & Day, M. L. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2158 · Cited by 172 · cited 6×
“Reduction of total E2F/DP activity induces senescence-like cell cycle arrest in cancer cells lacking functional pRB and p53.”
InfluentialSharpless, N. E., & DePinho, R. A. (2005) · Nature · doi:10.1038/436636a · Cited by 159 · cited 1×
“JCB: ARTICLE”
Multistep skin cancer in mice as a model to study the evolution of cancer cells
Kemp, C. J. (2005) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2005.06.003 · Cited by 159 · cited 1×
“In agreement with previous studies (Quintanilla et al., 1986; Kemp, 2005), benign skin papillomas began to appear after 7 wk of treatment and continued to grow to a larger 397REAL-TIME IN VIVO IMAGING OF P16 EXPRESSION • Yamakoshi et al. JCB • VOLUME 186 • NUMBER 3 • 2009 398 399REAL-TIME IN VIVO…”
Ndy1/KDM2B immortalizes mouse embryonic fibroblasts by repressing the Ink4a / Arf locus
Tzatsos, A., Pfau, R., Kampranis, S. C., & Tsichlis, P. N. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0813139106 · Cited by 147 · cited 1×
“…multiple levels of control (Jacobs et al., 1999; Passegué and Wagner, 2000; Ohtani et al., 2001, 2003; Gonzalez et al., 2006; Bracken et al., 2007; Kotake et al., 2007; Baker et al., 2008; Kia et al., 2008; Agger et al., 2009; Barradas et al., 2009; Tzatsos et al., 2009; Witcher and Emerson, 2009).”
Real-Time Quantitative PCR-based System for Determining Transgene Copy Number in Transgenic Animals
Ballester, M., Castelló, A., Ibáñez, E., Sánchez, A., & Folch, J. M. (2004) · BioTechniques · doi:10.2144/04374st06 · Cited by 136 · cited 1×
“The DNA sequence specific to this human chromosome segment was amplified and quantified by real-time PCR analysis (Ballester et al., 2004; Chandler et al., 2007) using genomic DNA prepared from the same number of early passage human diploid fibroblasts (HDFs) as a control.”
Site-specific DNA methylation by a complex of PU.1 and Dnmt3a/b
Suzuki, M., Yamada, T., Kihara-Negishi, F., Sakurai, T., Hara, E., Tenen, D. G., Hozumi, N., & Oikawa, T. (2006) · Oncogene · doi:10.1038/sj.onc.1209272 · Cited by 132 · cited 2×
“Bisulfite sequencing analysis Bisulfite sequencing analysis was performed as described previously (Suzuki et al., 2006).”
MethodSelf-citationFeedback Circuit among INK4 Tumor Suppressors Constrains Human Glioblastoma Development
Wiedemeyer, R., Brennan, C., Heffernan, T. P., Xiao, Y., Mahoney, J. E., Protopopov, A. I., Zheng, H., Bignell, G. R., Furnari, F. B., Cavenee, W. K., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.02.010 · Cited by 126 · cited 1×
“Representative data of five different experiments are shown. et al., 2007; Ramsey et al., 2007; Wiedemeyer et al., 2008).”
Chandler, K. J., Chandler, R. L., Broeckelmann, E. M., Hou, Y., Southard‐Smith, E. M., & Mortlock, D. P. (2007) · Mammalian Genome · doi:10.1007/s00335-007-9056-y · Cited by 124 · cited 1×
“The DNA sequence specific to this human chromosome segment was amplified and quantified by real-time PCR analysis (Ballester et al., 2004; Chandler et al., 2007) using genomic DNA prepared from the same number of early passage human diploid fibroblasts (HDFs) as a control.”
Epstein-Barr virus LMP1 blocks p16INK4a–RB pathway by promoting nuclear export of E2F4/5
Ohtani, N., Brennan, P., Gaubatz, S., Sanij, E., Hertzog, P. J., Wolvetang, E. J., Ghysdael, J., Rowe, M., & Hara, E. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200302085 · Cited by 115 · cited 1×
“…factors described in this study and that the p16Ink4a gene is subject to multiple levels of control (Jacobs et al., 1999; Passegué and Wagner, 2000; Ohtani et al., 2001, 2003; Gonzalez et al., 2006; Bracken et al., 2007; Kotake et al., 2007; Baker et al., 2008; Kia et al., 2008; Agger et al.,…”
Self-citationNormal Human Fibroblasts Are Resistant to RAS-Induced Senescence
Benanti, J. A., & Galloway, D. A. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.7.2842-2852.2004 · Cited by 103 · cited 2×
“, 1997; Serrano and Blasco, 2001; Campisi, 2005; Gil and Peters, 2006; Kim and Sharpless, 2006), freshly isolated HDFs are resistant to oncogenic Ras–induced senescence because of low level p16 gene expression (Benanti and Galloway, 2004).”
Maehara, K., Yamakoshi, K., Ohtani, N., Kubo, Y., Takahashi, A., Arase, S., Jones, N., & Hara, E. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200411093 · Cited by 96 · cited 1×
“For RNAi experiments, HDFs were infected with retrovirus encoding short hairpin RNA (shRNA) as described previously (Maehara et al., 2005).”
Self-citationAnti‐aging activity of the Ink4/Arf locus
Matheu, A., Maraver, A., Collado, M., Garcia‐Cao, I., Cañamero, M., Borras, C., Flores, J. M., Klatt, P., Viña, J., & Serrano, M. (2009) · Aging Cell · doi:10.1111/j.1474-9726.2009.00458.x · Cited by 94 · cited 1×
“S1 A), it is most likely that these seemingly contradictory data are, at least partly, caused by the difference of p16Ink4a activity between our mice and the mice of Matheu et al. (2009). nontransformed cells (Shay and Wright, 2007).”
p16(INK4a) and p53 deficiency cooperate in tumorigenesis.
Sharpless, N. E., Alson, S., Chan, S., Silver, D. P., Castrillón, D. H., & DePinho, R. A. (2002) · PubMed · Cited by 83
Macleod, K. F. (2008) · Nature reviews. Cancer · doi:10.1038/nrc2504 · Cited by 73 · cited 1×
“S5 A; Finkel and Holbrook, 2000; Macleod, 2008), and increased levels of ROS are shown to be essential for the onset of oncogenic Ras–induced senescence in cultured HDFs (Lee et al., 1999).”
Ohtani, N., Imamura, Y., Yamakoshi, K., Hirota, F., Nakayama, R., Kubo, Y., Ishimaru, N., Takahashi, A., Hirao, A., Shimizu, T., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706949104 · Cited by 73 · cited 4×
“The p16-luc mice were then subjected to noninvasive bioluminescence imaging (BLI) under anesthesia as described previously (Ohtani et al., 2007).”
InfluentialSelf-citationRamsey, M. R., Krishnamurthy, J., Pei, X., Torrice, C., Lin, W., Carrasco, D. R., Ligon, K. L., Xiong, Y., & Sharpless, N. E. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3437 · Cited by 70 · cited 1×
“Representative data of five different experiments are shown. et al., 2007; Ramsey et al., 2007; Wiedemeyer et al., 2008).”
ZHANG, D.-F., Shimizu, T., Araki, N., Hirota, T., Yoshie, M., Ogawa, K., Nakagata, N., Takeya, M., & Saya, H. (2008) · Oncogene · doi:10.1038/onc.2008.76 · Cited by 62 · cited 1×
“Indeed, it has previously been shown that overexpression of Aurora A resulted in a significant induction of p16Ink4a expression in the mammary glands of p53 knockout mice (Zhang et al., 2008).”
Self-citationShay, J. W., & Wright, W. E. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.07.012 · Cited by 25 · cited 1×
“gene expression is also induced by tissue culture–imposed stress (Ramirez et al., 2001; Benanti and Galloway, 2004; Ince et al., 2007; Shay and Wright, 2007), it remains unclear whether the induction of human p16 gene expression in tissuecultured cells truly reflects an anticancer process or an artifact of tissue cult…”
Cited by
Aging, Cellular Senescence, and Cancer
Campisi, J. (2013) · Annual Review of Physiology · doi:10.1146/annurev-physiol-030212-183653 · Cited by 2,954
Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome
Yoshimoto, S., Loo, T. M., Atarashi, K., Kanda, H., Sato, S., Oyadomari, S., Iwakura, Y., Oshima, K., Morita, H., Hattori, M., et al. (2013) · Nature · doi:10.1038/nature12347 · Cited by 2,219
Self-citationAn Essential Role for Senescent Cells in Optimal Wound Healing through Secretion of PDGF-AA
Demaria, M., Ohtani, N., Youssef, S. A., Rodier, F., Toussaint, W., Mitchell, J. R., Laberge, R.-M., Vijg, J., Van Steeg, H., Dollé, M. E. T., et al. (2014) · Developmental Cell · doi:10.1016/j.devcel.2014.11.012 · Cited by 2,045
“We chose as a senescence-sensitive promoter that of the tumor suppressor p16, which has been used to track senescent cells in other mouse models (Baker et al., 2011; Burd et al., 2013; Yamakoshi et al., 2009).”
Self-citationThe essence of senescence: Figure 1.
Kuilman, T., Michaloglou, C., Mooi, W. J., & Peeper, D. S. (2010) · Genes & Development · doi:10.1101/gad.1971610 · Cited by 2,038
“In addition, murine papillomas driven by HRASV12 expression or induced upon DMBA/TPA treatment express several senescence markers (Collado et al. 2005; Acosta et al. 2008; Chen et al. 2009; Yamakoshi et al. 2009).”
BackgroundFour faces of cellular senescence
Rodier, F., & Campisi, J. (2011) · Journal of Cell Biology · doi:10.1083/jcb.201009094 · Cited by 2,070
“There is mounting evidence that these pathways interact and modulate each other (Zhang et al., 2006; Leong et al., 2009; Su et al., 2009; Yamakoshi et al., 2009).”
Metadata
- Authors
- Yamakoshi, K., Takahashi, A., Hirota, F., Nakayama, R., Ishimaru, N., Kubo, Y., Mann, D. J., Ohmura, M., Hirao, A., Saya, H., Arase, S., Hayashi, Y., Nakao, K., Matsumoto, M., Ohtani, N., & Hara, E.
- Affiliations
- Japanese Foundation For Cancer Research (JP)
- Tokushima University (JP)
- RIKEN (JP)
- Imperial College London (GB)
- Kanazawa University (JP)
- Keio University (JP)
- Corresponding author
- Ohtani, Naoko
- Hara, Eiji
- ORCID
- Venue
- Journal of Cell Biology
- Publisher
- Rockefeller University Press
- Published
- 2009-08-10
- Volume
- 186
- Issue
- 3
- Pages
- 393-407
- ISSN
- 0021-9525 (ISSN-L)
- 1540-8140
- PMC
- PMC2728398
- OpenAlex
- W2148949613
- Semantic Scholar
- 79b77b1b2763b45eb5be74df1894aeb89cd0d75b
- Cited by
- 172
- References
- 71
- Citations by year
- 2026: 11 · 2025: 6 · 2024: 14 · 2023: 14 · 2022: 19 · 2021: 13 · 2020: 14 · 2019: 11 · 2018: 5 · 2017: 12 · 2016: 7 · 2015: 11 · 2014: 7 · 2013: 8 · 2012: 7
- FWCI
- 3.33
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- cc-by-nc-sa
- Locations
- The Journal of Cell Biology (publishedVersion)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Funders
- Japan Society for the Promotion of Science (21390290)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Keywords
- p16INK4a, p53, tumor suppressor, epigenetic derepression, DNMT1, DNA methylation, DNA damage response, oncogenic stress, Ras activation, bioluminescence imaging, in vivo gene expression
- MeSH terms
- Animals, Cells, Cultured, Disease Models, Animal, Humans, Mice, Inbred C57BL, Mice, Transgenic, Time Factors, Tumor Suppressor Protein p53, Mice, Knockout, Cyclin-Dependent Kinase Inhibitor p16, Reverse Transcriptase Polymerase Chain Reaction, Gene Expression Profiling, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.